Rapidly progressive interstitial lung disease (RP-ILD) is a severe complication of juvenile dermatomyositis (JDM), particularly when associated with anti-melanoma differentiation-associated gene 5 (anti-MDA5) antibodies [2–5]. This evidence concerns the gene IFIH1 and juvenile dermatomyositis.